Building a heart, kidney, and metabolic disease registry

Plain-English translation of NCT07547098 on ClinicalTrials.gov ↗ · Source last updated April 2026 · Translation generated July 2026 · How we translate trials

What is this trial?

This is a registry study — meaning researchers will gather your medical records, test results, and imaging scans from the hospital and follow up with you over 5 years. The goal is to understand how heart disease, kidney disease, and metabolic conditions (like diabetes or high cholesterol) connect and affect patient outcomes. By collecting information from thousands of patients, researchers hope to identify which people are at highest risk and develop better ways to predict and treat these conditions.

Many patients have heart, kidney, and metabolic problems at the same time, but doctors don't fully understand how these conditions interact or how to best care for them together. This study aims to fill that gap by creating a comprehensive database that tracks real patients over time, helping doctors recognize patterns and improve how they treat and prevent these diseases.

Do you qualify?

You likely qualify if…

you are 18 to 80 years old
you are being treated as an inpatient at the First Affiliated Hospital of Fujian Medical University
you have been diagnosed with heart disease, kidney disease, metabolic disease, or have test results that fit these patterns
you are willing and able to provide written informed consent
you can complete baseline assessments and attend follow-up visits
you have the mental capacity to understand the study information

You likely don't qualify if…

you refuse to sign a written informed consent form
you have severe psychiatric illness or cognitive problems that prevent you from participating
you have end-stage disease with an expected survival of less than 1 year
you plan to be away for more than 6 months, making follow-up impossible
you are already enrolled in another clinical study that might interfere with tracking outcomes

What participation looks like

Researchers will access your hospital records, lab results, and imaging studies that you've already had done. You'll be contacted for annual active follow-up conversations and check-ins, while the hospital will share updated medical information monthly. Over the 5-year study period, the team will monitor how your conditions change and track major health events — all to help build a better understanding of how heart, kidney, and metabolic diseases connect and progress.

AI-generated summary from trial data · Jul 20, 2026 · Not medical advice

Trial locations(1 site)

China

The First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian